Position in CNMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,258,370
+$124,550 QoQ
Shares Held
69,000
+95.3% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 245 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CNMD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NATIXIS holds $149,303,624 across 13 Medical Devices names. CNMD ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
144,712 | $45,561,126 | |
| 2 | PEN |
Penumbra Inc
|
124,458 | $39,297,613 | |
| 3 | ABT |
Abbott Laboratories
|
185,746 | $16,854,592 | |
| 4 | EW |
Edwards Lifesciences Corp
|
183,344 | $16,585,298 | |
| 5 | PODD |
Insulet Corp
|
79,197 | $12,057,743 | |
| 6 | BSX |
Boston Scientific Corp
|
168,036 | $7,171,776 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
67,365 | $4,312,033 | |
| 8 | AHCO |
AdaptHealth Corp.
|
350,000 | $3,647,000 |
All Filings in CNMD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,258,370 | 69,000 | Shares | Sole | 2026-08-13 | |
| 2025-03-31 | $2,133,820 | 35,334 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $7,802,160 | 114,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $701,220 | 9,750 | Shares | Sole | 2024-11-13 | |
| 2023-12-31 | $6,428,237 | 58,700 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,526,580 | 54,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,709,918 | 19,942 | Shares | Sole | 2023-08-11 | |
| 2022-09-30 | $8,237,467 | 102,750 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||